Dermapharm Holding SE

DMPHF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$48$33$50$35
Dep. & Amort.$25$20$20$24
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$2$16-$40$27
Other Non-Cash-$22-$3-$25-$14
Operating Cash Flow$52$66$4$72
Investing Activities
PP&E Inv.-$11-$10-$10-$12
Net Acquisitions$0$0$0$0
Inv. Purchases-$13$0$0$1
Inv. Sales/Matur.$1$0$0$0
Other Inv. Act.$0$1$1$3
Investing Cash Flow-$23-$10-$9-$8
Financing Activities
Debt Repay.$11$35$23-$53
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$57$0$0$0
Other Fin. Act.-$2-$42-$23-$9
Financing Cash Flow-$48-$7-$0-$62
Forex Effect-$1-$2-$1$1
Net Chg. in Cash-$20$48-$6$3
Supplemental Information
Beg. Cash$192$115$121$118
End Cash$172$163$115$121
Free Cash Flow$41$55-$6$60